Abstract
In vitro drug metabolism from liver and kidney of rats was studied for up to 12 days following a single intraperitoneal injection of the antineoplastic drug cisplatinum. At 3, 5, and 8 days posttreatment, hepatic cytochrome P-450 dependent enzyme activity was increased 20–45%, but levels of cytochromes P-450 and b5 were unaltered. Hepatic in vitro stimulated thiobarbituric acid reactive (TBAR) substances were increased at all times, with a maximum of 20 times normal on day 5. Renal aniline hydroxylase activity was elevated 25–95% throughout the first 8 days. Renal in vitro stimulated TBAR substances were not significantly altered. In vitro addition of cisPt to control microsomes resulted in no consistent, dose-related changes in substrate metabolism.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 46-53 |
| Number of pages | 8 |
| Journal | Pharmacology |
| Volume | 26 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1983 |
| Externally published | Yes |
Keywords
- Cisplatinum
- Hepatic drug metabolism
- In vitro drug metabolism
- Microsomal drug metabolism
- Renal drug metabolism
ASJC Scopus subject areas
- Pharmacology
Fingerprint
Dive into the research topics of 'Stimulation of microsomal drug oxidation in liver and kidney of rats treated with the oncolytic agent cis-dichlorodiammineplatinum-II'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS